HomeAnswersPulmonology (Asthma Doctors)lung cancer

Can clinical trials cure stage 4 lung cancer in patients aged 28?

This Premium Q&A, reviewed and published, features a real conversation between an iCliniq user and a physician.

Patient's Query

Hello doctor,

I am 28 and recently diagnosed with stage 4 lung cancer. Doctors started standard treatment, but also mentioned clinical trials as an option. I keep reading mixed opinions online and feel confused.

  1. Can clinical trials cure stage 4 lung cancer in young patients at 28?

  2. Are trials meant only when standard treatment fails, or can they be used earlier?

  3. Do young patients usually respond better to experimental therapies?

I do not want false hope, but also do not want to miss a chance that could help long-term survival.

Please help.
Answered by Dr. Amandeep Singh Arneja

Education:

MD RESPIRATORY MEDICINE

Professional Bio:

I am Dr. Amandeep Singh Arneja, a dedicated Chest Physician and Senior Resident in Pulmonary Medicine at Jawaharlal Nehru Medical College (JNMC), Wardha, with extensive training in the management of complex respiratory and critical care conditions. I completed my M.B.B.S. from Universal College of Medical Sciences, Tribhuvan University (2016) and M.D. in Respiratory Medicine from Shri Shankaracharya Institute of Medical Sciences, Bhilai (2025), where I gained hands-on expertise in managing ICU patients, performing advanced diagnostic and therapeutic procedures, and conducting research in pulmonary diseases. My areas of expertise include: Management of asthma, COPD, tuberculosis, and interstitial lung disease Critical care management (ICU care, mechanical ventilation) Pulmonary function testing (spirometry, DLCO) Interventional procedures (thoracentesis, ICD insertion, bronchoscopy) Sleep medicine and polysomnography Research, academic writing, and clinical presentations I hold certifications in Good Clinical Practice and Biomedical Research. I am a proud member of the National College of Chest Physicians (NCCP). Alongside my pulmonary expertise, I have also completed a CPCDM Fellowship in Diabetes from RSSDI, enabling me to provide holistic care for patients with respiratory diseases complicated by diabetes. Currently, I am also pursuing a Fellowship in Critical Care Medicine, which further enhances my ability to manage critically ill patients with respiratory and systemic illnesses. With multiple research publications, conference presentations (NAPCON, SSIMSCON), and a strong academic background, I strive to combine evidence-based medicine with compassionate patient care. My mission is to provide comprehensive, high-quality care to patients suffering from respiratory and lifestyle-related diseases.

This doctor is not available for online consultations on the platform anymore.

Consult other doctors in the same speciality

Hello,

Welcome to icliniq.com.

I understand how confusing this situation can feel, especially when you start reading different opinions on the internet about clinical trials. Many patients worry that they might miss an important opportunity, while at the same time, they do not want to rely on unrealistic expectations.

Clinical trials are research studies where new drugs or treatment strategies are tested to see if they work better than the current standard treatments.

In stage 4 lung cancer, the aim of treatment is usually long-term disease control rather than cure.

Some newer drugs being studied in trials, especially targeted therapies and immunotherapy, have helped certain patients keep the disease controlled for many years.

However, it would not be medically correct to say that clinical trials reliably cure stage 4 lung cancer.

Clinical trials are not only used after standard treatment fails. In many cancer centers, they can be offered earlier as well, depending on the type of lung cancer, the genetic profile of the tumor, and the design of the trial.

Some trials actually compare a new treatment directly with the current standard therapy, so patients may receive either the established treatment or the newer therapy being studied.

Being young can sometimes help because younger patients usually tolerate treatment better and recover from side effects more easily. However, response to therapy mainly depends on the biology of the tumor, especially the genetic mutations present in the cancer cells.

In younger non-smokers, lung cancers are often driven by specific molecular mutations, and if a treatment or trial is designed for that mutation, responses can sometimes be quite good.

I have seen a few young patients where newer targeted therapies controlled the disease for several years.

I hope you find this helpful. Do follow up whenever needed.

Thank you.

Medically reviewed by iCliniq medical review team
Published At May 7, 2026
Reviewed At May 7, 2026

Education:

MD RESPIRATORY MEDICINE

Professional Bio:

I am Dr. Amandeep Singh Arneja, a dedicated Chest Physician and Senior Resident in Pulmonary Medicine at Jawaharlal Nehru Medical College (JNMC), Wardha, with extensive training in the management of complex respiratory and critical care conditions. I completed my M.B.B.S. from Universal College of Medical Sciences, Tribhuvan University (2016) and M.D. in Respiratory Medicine from Shri Shankaracharya Institute of Medical Sciences, Bhilai (2025), where I gained hands-on expertise in managing ICU patients, performing advanced diagnostic and therapeutic procedures, and conducting research in pulmonary diseases. My areas of expertise include: Management of asthma, COPD, tuberculosis, and interstitial lung disease Critical care management (ICU care, mechanical ventilation) Pulmonary function testing (spirometry, DLCO) Interventional procedures (thoracentesis, ICD insertion, bronchoscopy) Sleep medicine and polysomnography Research, academic writing, and clinical presentations I hold certifications in Good Clinical Practice and Biomedical Research. I am a proud member of the National College of Chest Physicians (NCCP). Alongside my pulmonary expertise, I have also completed a CPCDM Fellowship in Diabetes from RSSDI, enabling me to provide holistic care for patients with respiratory diseases complicated by diabetes. Currently, I am also pursuing a Fellowship in Critical Care Medicine, which further enhances my ability to manage critically ill patients with respiratory and systemic illnesses. With multiple research publications, conference presentations (NAPCON, SSIMSCON), and a strong academic background, I strive to combine evidence-based medicine with compassionate patient care. My mission is to provide comprehensive, high-quality care to patients suffering from respiratory and lifestyle-related diseases.

This doctor is not available for online consultations on the platform anymore.

Consult other doctors in the same speciality

Same symptoms don't mean you have the same problem. Consult a doctor now!

Dr. Amandeep Singh Arneja
Dr. Amandeep Singh Arneja

Pulmonology (Asthma Doctors)

Education:

MD RESPIRATORY MEDICINE

Professional Bio:

I am Dr. Amandeep Singh Arneja, a dedicated Chest Physician and Senior Resident in Pulmonary Medicine at Jawaharlal Nehru Medical College (JNMC), Wardha, with extensive training in the management of complex respiratory and critical care conditions. I completed my M.B.B.S. from Universal College of Medical Sciences, Tribhuvan University (2016) and M.D. in Respiratory Medicine from Shri Shankaracharya Institute of Medical Sciences, Bhilai (2025), where I gained hands-on expertise in managing ICU patients, performing advanced diagnostic and therapeutic procedures, and conducting research in pulmonary diseases. My areas of expertise include: Management of asthma, COPD, tuberculosis, and interstitial lung disease Critical care management (ICU care, mechanical ventilation) Pulmonary function testing (spirometry, DLCO) Interventional procedures (thoracentesis, ICD insertion, bronchoscopy) Sleep medicine and polysomnography Research, academic writing, and clinical presentations I hold certifications in Good Clinical Practice and Biomedical Research. I am a proud member of the National College of Chest Physicians (NCCP). Alongside my pulmonary expertise, I have also completed a CPCDM Fellowship in Diabetes from RSSDI, enabling me to provide holistic care for patients with respiratory diseases complicated by diabetes. Currently, I am also pursuing a Fellowship in Critical Care Medicine, which further enhances my ability to manage critically ill patients with respiratory and systemic illnesses. With multiple research publications, conference presentations (NAPCON, SSIMSCON), and a strong academic background, I strive to combine evidence-based medicine with compassionate patient care. My mission is to provide comprehensive, high-quality care to patients suffering from respiratory and lifestyle-related diseases.

This doctor is not available for online consultations on the platform anymore.

Consult other doctors in the same speciality
Listen to related tracks in our music library

Related Questions

What does it mean to have a growing mass in the iliac region?

Dupilumab - Uses, Dosage, Side-Effects, Precautions, Clinical Trials Result

Are clinical trials safe for me with stage 3 lung cancer?

Can chemotherapy cure prostate cancer in the elderly?

Lung Cancer Screening: Racial and Ethnic Disparities

Lung Cancer and Skin: Exploring the Association

Comprehensive Second Opinion

Read answers about:

stage 4 cancerclinical trialslung cancer

Ask your health query to a doctor online

Pulmonology (Asthma Doctors)

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.